The prostate is the most frequent site of cancer in men aged 68 years and older. Although prostate cancer is frequently a slow-progressing cancer, the increase in lifespan is posing new challenges in order to avoid prostate cancer-associated mortality.
Today, health operators are mainly worried about two worldwide trends in human conditions: the remarkable increases in life expectancy and in obesity prevalence. These two aspects appear interconnected, and in the last decades a progressive gain in the body weight of older people has been observed. Considering 65 years of age as the threshold of access into the elderly population, it is expected that the number of older adults will increase to approximately 20 % of the US population by 2030, 1 and the large majority of these older people will be overweight.
In fact, in the US population for men aged 60 or over the median body mass index (BMI) was progressively increasing in the last ten years of the past century. 2 As a result, in most developed countries middle-aged and elderly adults are more likely to be obese than people in any other age group.
The prevalence of obesity, defined as an excess amount of body fat, has increased substantially in the past half-century, worldwide. Besides genetic background, the main causal contributors responsible for the increased prevalence of obesity include the modern lifestyle associated with reduced physical activity, food abundance and unhealthy diet. The worldwide prevalence of obesity nearly doubled between 1980
and 2008. A current estimate is that roughly one-third of US adults and one-fifth of European adults are obese. 3, 4 Advanced age and obesity are both independent and well-known risk factors for chronic health conditions, also including several types of cancer. Growing older is the greatest risk factor for cancer and about 80 % of all cancers are diagnosed in persons aged 55 and older.
Prostate cancer (PCa) is the most frequently diagnosed malignancy in American and European men. In the US the median age at the time of PCa diagnosis during 2002-2006 was 68 years, with the highest incidence rate reported in men aged 70-74. 5 At diagnosis PCa, like many other solid tumours, has a long preceding natural history that started several years before. It is plausible that the number of years overweight has the most important impact on the risks of PCa in old age. Unfortunately, prospective studies with sufficient duration and follow-up time in this matter are lacking and the majority of epidemiological studies are limited to monitoring obesity at diagnosis.
However, in consequence of recent data, it is likely that even recent onset of obesity in old age may accelerate PCa progression and worsen the associated conditions. The new key evidence supporting this hypothesis suggests that obesity-related health consequences may be exacerbated by age-related dysfunction in adipose tissue metabolism. In obese individuals the normal homoeostasis in visceral fat deposits is significantly perturbed and this in turn is able to disturb the systemic metabolism. Older persons are particularly vulnerable to obesity-related dysregulation because they have a limited capacity to maintain homoeostasis and to respond to internal stress. The most commonly suggested multi-system impairments in the elderly involve dysregulation of the neuromuscular, endocrine and immune systems. Low-level inflammation, sarcopenia, osteopenia and nutritional changes are diagnosed. Thus obesity may worsen the outlook of risk resulting from age -or disease-associated physiological frailty.
The false belief that adipose tissue was limited in function to lipid synthesis, storage and breakdown began to be reconsidered in the early 1990s with the discovery that the pro-inflammatory cytokine tumour necrosis factor-α (TNF-α) is synthesised and released by adipocytes. 6 Subsequent studies have permitted a multiplicity of factors secreted by adipose tissue to be identified, that are collectively termed adipokines (see Table 1 ). Table 2 ). Obesity, and also old age, can lead to changes in the cellular composition of the fat pad, as well as to the modulation of individual cell phenotypes. Important changes affect the amount and activation of macrophages, the status of the vasculature and the activation of fibroblasts towards a fibrotic phenotype. 9 All these events are associated with the induction of a pro-inflammatory status.
It has been shown that obesity is associated with a state of low-grade chronic inflammation, with infiltrating macrophages within adipose tissue and elevated concentrations of inflammatory markers, including TNF-α, interleukin-6 (IL-6) and C-reactive protein. 10, 11 A strict functional analogy between pre-adipocytes and immune cells seems to exist, but the bases of this similarity are largely unexplored.
Adipose tissue and bone marrow share an embryological origin, the mesoderm, and pre-adipocytes are potent phagocytes that resemble macrophages in both morphology and patterns of gene expression. 
Obesity in the Elderly
Obesity is a chronic condition that can be prevented but it is difficult to reverse. Over 60 % of children who are overweight before puberty will be overweight in early adulthood. This is particularly true in older adults who are often less likely to change long-standing health behaviours.
Moreover, a diminished β-adrenergically mediated thermogenesis and a decreased basal metabolic rate may contribute in older adults to a
Obesity in the Elderly -On the Role of Adipokines in Prostate Cancer Progression positive energy balance and thus promote increased fat storage and obesity. 15 However, the main cause of obesity in developed countries is a decrease in energy expenditure which is primarily due to decreased physical activity in conjunction with an energy-dense diet.
Obesity is considered as one of the greatest long-term health threats for humans in both developed and developing countries. 4 Worldwide, 2.8 million people, about 8 % of total deaths due to non-communicable diseases, die each year as a result of being overweight. Obesity is undoubtedly related to several diseases and disabilities; moreover, an independent association between obesity and all-cause mortality has been demonstrated in adults. 16, 17 The risks of coronary heart disease, 
Obesity and Prostate Cancer
Migrant studies have clearly demonstrated that environmental factors and lifestyle may explain the geographical variation in cancer incidence. Epidemiological data are concordant in suggesting that
PCa rates of Asian immigrants in the US significantly increase with respect to those in their homelands. 31, 32 One of the largest geographical disparities in incidence among cancers is observed in PCa; incidence differs 60-fold between US and Chinese men.
However, the observation that Chinese-and Japanese-Americans have rates that are much higher than their counterparts in China and Japan supports a role for environmental rather than genetic factors. 33 Among the underlying risk factors present in immigrant countries, overweight and obesity account for 15-20 % of all cancer deaths. 34 In the last years of the past century a large increase in cancer incidence in low-risk countries has been reported, independently from an improvement in diagnosis methods. 35, 36 Such increases are concurrent with westernisation in these populations, suggesting that changes in the prevalence of certain common potential risk factors, such as dietary fat, obesity and physical activity, may have contributed at least in part to the progression and rising rates of PCa. 37, 38 In addition to ageing, the aetiology of sporadic PCa is very heterogeneous. However, data on other risk factors, such as circulating levels of hormones, physical activity, body size, smoking, drinking, sexual behaviour and occupational exposures, are conflicting. 39 Genetic factors have been invoked to explain the higher incidence rates reported for African-Americans with respect to white Americans, but also in this case available data about population-based incidence rates in Africa, although incomplete and scarcely comparable, indicate much lower incidence rates than the rates reported for African-Americans. 33 Pca is a slow-growing cancer with a long latency period. The prevalence of latent tumours has been shown to be quite high in the elderly population, affecting about 50 % of men over the age of 70. 40 Thus cancer-promoting factors may significantly change the impact of PCa on life expectancy. Because of the median age at diagnosis and the slow growing rate of the tumour, it is probable that the cause of death in patients affected by PCa will be independent of cancer. It has been stated many times that most elderly men die with PCa rather than because of PCa, since so many cases of the disease grow indolently and are clinically irrelevant.
Interestingly, despite the large disparity in incidence between US and Asian men, autopsy studies have shown that there is little variation in the prevalence of latent PCa across countries. 41 Thus environmental factors may be responsible for the progression from latent to clinically significant tumours. 33 Significantly, recent studies suggest a reverse association between BMI and cancer grading: reduced risk of low-grade PCa and increased risk of high-grade PCa. 42 This phenomenon is particularly evident if patients are stratified according to age. In fact, the reduced risk of low-grade PCa was evident in younger obese men (aged <60 years). 43 A substantial contribution of age was also suggested by a large prospective study that reported a more pronounced risk of all grades of PCa in obese men older than 45 years. 44 Accordingly, several studies have confirmed a consistent positive association between obesity and PCa mortality. 34, 45 In the American Cancer Society cancer prevention study-II (CPS-II) nutrition cohort, a higher BMI was associated with a lower risk of non-metastatic low-grade PCa, but a higher risk of high-grade, metastatic and fatal PCa. 42 The largest prospective trial in this area included a total of 950,000 men and found a 9 % excess of PCa in obese individuals. 44 A recent study including 441 men showed that the association of PCa with obesity could be underestimated because important diagnostic characteristics correlate with obesity. In fact, the authors found that obese men had lower prostate-specific antigen (PSA) values and larger prostate volumes and, after adjusting for confounding variables, obesity was significantly associated with a 98 % increase in PCa risk. 46 Several mechanisms have been proposed that could explain the association of obesity with PCa risk, including sex steroid hormones, insulin, insulin-like growth factor (IGF) and adipokine signalling.
Particular attention was reserved for the potential role of testosterone, because of its association with the initial progression of PCa. However, obesity is generally associated with a decreased concentration of serum testosterone, and the observed association with high-grade PCa has not found a plausible molecular explanation. 47 The concomitant observation that obesity is associated with substantially lower concentrations of sex hormone-binding globulin and higher concentrations of oestrogens underscores the complex interrelations between obesity and serum sex steroids and their differential effect on PCa. 48 However, further studies are needed to resolve the possible connection.
It is well known that elderly populations suffer from vitamin D (vitD)
deficiency that leads to impaired bone mineralisation. As indicated by two large studies, most older people had low serum levels, and at least 25 % of elderly people had frank vitD deficiency. 49, 50 Hypovitaminosis D has also been frequently reported in obese individuals, and multiple mechanisms have been proposed to explain this association, including metabolic factors and lifestyle. 51 Fat accumulation may be an important co-factor predisposing elders to decreased bioavailability of vitD because of its deposition in body fat compartments. The adverse health effects of vitD deficiency could extend well beyond bone disease to encompass excess risk of cardiovascular diseases, autoimmune diseases and cancer, particularly colon, prostate and breast cancer. 52 However, a direct association between vitD levels and PCa risk in older men has not been consistently demonstrated, 53 necessitating rigorously controlled studies that take into account the many confounding co-factors associated with lifestyle and dietary habits.
Systemic Inflammation and Metabolic Syndrome
At present, the strongest empirical support for mechanisms to Moreover, increasing age was associated with a reduced five-year overall survival. 54 The presence of high levels of C-reactive protein, at diagnosis, predicts a poor long-term cancer outcome in patients with localised PCa. 55 Insulin resistance is associated with increased free or bioavailable IGF-1. 61 Whereas few studies have investigated the role of insulin in PCa, a positive association between IGF-1 and PCa risk was reported. 62 However, epidemiological studies in the elderly have demonstrated this association to be particularly complex, because of the constellation of metabolic abnormalities accompanying older age. Although the more Obesity in the Elderly -On the Role of Adipokines in Prostate Cancer Progression 
Leptin and Adiponectin
The dual control by adipose tissue of energy metabolism and the immune system is well demonstrated by two adipokines with opposite functions, leptin and adiponectin. In recent years, both adipokines have received particular interest for their capacity to modulate cancer cell phenotype directly.
Leptin is a small adipokine produced predominantly by adipocytes.
Circulating leptin levels are higher in obese individuals with respect to lean subjects. Leptin exerts a complex control of energy homoeostasis, modulating different organs and systemic metabolism. During fasting, when plasma leptin levels decline, neural pathways in the hypothalamus cause appetite to increase and energy expenditure to decrease, an attempt to restore body fat stores. 65 Leptin suppresses the appetite through the production of anorexigenic peptides by the hypothalamus. In animal models the central anorexigenic action of leptin is clearly diminished in ageing, most probably due to the impaired signal transduction in hypothalamic neurons. Because aged obese rats are leptin-resistant, these data predict that they will also have a delayed normalisation of caloric intake and exacerbated weight gain when provided with a high-fat diet. These results demonstrate that aged rats are more susceptible to the detrimental effects of a high-fat diet. 66 Whether a similar mechanism is also valid in humans remains to be proven. In addition, the fall in plasma leptin diminishes thyroid hormone production 67 and inhibits the reproductive axis, both effects that save energy during nutritionally lean times. 68 Importantly, leptin has been indicated as a key factor in the development and maintenance of murine and human reproductive tissues, including the prostate. 69 The leptin receptor is expressed on prostatic epithelial cells, and thus leptin may directly modulate the development and homoeostasis of prostatic tissue. Maturation of the prostate gland continues while embryonic testosterone levels are high; however, as testosterone levels fall during the third trimester of gestation, the gland enters a quiescent state. The quiescent state persists until puberty, when testosterone levels increase again and the epithelium proliferates, giving rise to the mature gland. It is plausible that leptin may exert a role in this phase of gland reactivation just prior to the increase in testosterone levels. In fact, current evidence suggests that leptin plays a permissive role in timing sexual development. 70 The leptin dependence in prostatic epithelial cells can be reactivated in elderly men following the tumour transformation. In fact, the expression of the leptin receptor is significantly higher in PCa than in both benign prostatic hyperplasia and normal prostatic tissue. 71 The higher the blood leptin concentration, the greater the negative effect on cellular differentiation and the positive one on cancer progression in PCa. 72 The available data do not unequivocally indicate a positive correlation between blood leptin levels and PCa risk. On the contrary, there are more convincing indications that elevated plasma leptin concentration is predictive of high-grade disease and more advanced tumours. 73, 74 Results from in vitro studies support such a relationship. In fact, leptin treatment of PCa cells determines the activation of intracellular signalling pathways associated with proliferation, migration and invasion. 74, 75 Adiponectin Plasma adiponectin levels are negatively correlated with C-reactive protein levels in obese or diabetic patients, and the administration of adiponectin in obese animals improves inflammation-associated pathological outcomes. 76, 77 In adipose tissue adiponectin can interfere in the differentiation of macrophages towards a pro-inflammatory M1
subtype, reducing the production of reactive oxygen species. 78 Adiponectin receptors are expressed in PCa cell lines and in benign and malignant human prostate tissues, 79 and it is associated with a marked reduction in the risk of PCa. 80 Lower adiponectin levels are independently associated with high-grade PCa.
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Conclusions
The recent growing prevalence of overweight and obesity among older adults has synergised with a substantial change in demographic curves in industrialised countries towards an elderly population. This In order to dissect these mechanisms, a clearer understanding of the cellular and molecular changes in adipose tissue is needed. n Prostate Cancer
